PMC:7160614 / 14953-16759 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"194","span":{"begin":92,"end":100},"obj":"Disease"},{"id":"195","span":{"begin":110,"end":118},"obj":"Disease"},{"id":"199","span":{"begin":42,"end":50},"obj":"Species"},{"id":"200","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"201","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"203","span":{"begin":1557,"end":1560},"obj":"Chemical"}],"attributes":[{"id":"A194","pred":"tao:has_database_id","subj":"194","obj":"MESH:C000657245"},{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"MESH:C000657245"},{"id":"A199","pred":"tao:has_database_id","subj":"199","obj":"Tax:9606"},{"id":"A200","pred":"tao:has_database_id","subj":"200","obj":"MESH:C000657245"},{"id":"A201","pred":"tao:has_database_id","subj":"201","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 1 Radiological semantic features of patients in COVID-19 and non-COVID-19\nFeature Non-COVID-19 (n = 66) COVID-19 (n = 70) p value\nNumber of pure GGO\n  Total# 1.00 (0.00, 5.05) 3.50 (0.95, 8.05) 0.018b*\n  Peripheral area# 1.00 (0.00, 4.05) 2.00 (0.00, 6.05) 0.032b*\n  Central/both peripheral and central area# 0.00 (0.00, 0.00) 0.00 (0.00, 2.00) 0.001b*\nNumber of mixed GGO\n  Total# 1.00 (0.00, 3.05) 3.00 (1.00, 9.00) 0.001b*\n  Peripheral area# 0.00 (0.00, 2.00) 2.50 (1.00, 6.00) \u003c 0.001b*\n  Central/both peripheral and central area# 0.00 (0.00, 1.05) 0.00 (0.00, 2.00) 0.657b\nTotal number of consolidation\n  Consolidation# 1.00 (0.00, 3.00) 0.00 (0.00, 0.05) 0.001b*\n  Pure solid nodules# 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.309b\n  Solid nodules with GGO# 0.00 (0.00, 0.00) 0.00 (0.00, 1.00) 0.033b*\nTotal number of lesions\n  Peripheral area# 5.00 (2.00, 9.05) 7.00 (2.00, 13.00) 0.112b\n  Central area# 0.00 (0.00, 3.00) 0.00 (0.00, 1.05) 0.960b\n  Both peripheral and central area# 0.00 (0.00, 2.00) 0.00 (0.00, 2.05) 0.582b\nInterlobular septal thickening 0.009a*\n  Negative 44 (66.67%) 31 (44.29%)\n  Positive 22 (33.33%) 39 (55.71%)\nCrazy paving pattern \u003c 0.001a*\n  Negative 60 (90.91%) 32 (45.71%)\n  Positive 6 (9.09%) 38 (54.29%)\nTree-in-bud sign \u003c 0.001a*\n  Negative 37 (56.06%) 61 (87.14%)\n  Positive 29 (43.94%) 9 (12.86%)\nPleural thickening 0.030a*\n  Negative 46 (69.70%) 36 (51.43%)\n  Positive 20 (30.30%) 34 (48.57%)\nOffending vessel augmentation in lesions \u003c 0.001a*\n  Negative 55 (83.33%) 17 (24.29%)\n  Positive 11 (16.67%) 53 (75.71%)\nGGO ground-glass opacities\n#Results are median with interquartile range in parentheses, and the remainder results are measurements with corresponding ratio in parentheses\n*Data with statistical significance. pa: chi-square test, pb: Student’s t test"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T20","span":{"begin":1446,"end":1452},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0000055"}],"text":"Table 1 Radiological semantic features of patients in COVID-19 and non-COVID-19\nFeature Non-COVID-19 (n = 66) COVID-19 (n = 70) p value\nNumber of pure GGO\n  Total# 1.00 (0.00, 5.05) 3.50 (0.95, 8.05) 0.018b*\n  Peripheral area# 1.00 (0.00, 4.05) 2.00 (0.00, 6.05) 0.032b*\n  Central/both peripheral and central area# 0.00 (0.00, 0.00) 0.00 (0.00, 2.00) 0.001b*\nNumber of mixed GGO\n  Total# 1.00 (0.00, 3.05) 3.00 (1.00, 9.00) 0.001b*\n  Peripheral area# 0.00 (0.00, 2.00) 2.50 (1.00, 6.00) \u003c 0.001b*\n  Central/both peripheral and central area# 0.00 (0.00, 1.05) 0.00 (0.00, 2.00) 0.657b\nTotal number of consolidation\n  Consolidation# 1.00 (0.00, 3.00) 0.00 (0.00, 0.05) 0.001b*\n  Pure solid nodules# 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.309b\n  Solid nodules with GGO# 0.00 (0.00, 0.00) 0.00 (0.00, 1.00) 0.033b*\nTotal number of lesions\n  Peripheral area# 5.00 (2.00, 9.05) 7.00 (2.00, 13.00) 0.112b\n  Central area# 0.00 (0.00, 3.00) 0.00 (0.00, 1.05) 0.960b\n  Both peripheral and central area# 0.00 (0.00, 2.00) 0.00 (0.00, 2.05) 0.582b\nInterlobular septal thickening 0.009a*\n  Negative 44 (66.67%) 31 (44.29%)\n  Positive 22 (33.33%) 39 (55.71%)\nCrazy paving pattern \u003c 0.001a*\n  Negative 60 (90.91%) 32 (45.71%)\n  Positive 6 (9.09%) 38 (54.29%)\nTree-in-bud sign \u003c 0.001a*\n  Negative 37 (56.06%) 61 (87.14%)\n  Positive 29 (43.94%) 9 (12.86%)\nPleural thickening 0.030a*\n  Negative 46 (69.70%) 36 (51.43%)\n  Positive 20 (30.30%) 34 (48.57%)\nOffending vessel augmentation in lesions \u003c 0.001a*\n  Negative 55 (83.33%) 17 (24.29%)\n  Positive 11 (16.67%) 53 (75.71%)\nGGO ground-glass opacities\n#Results are median with interquartile range in parentheses, and the remainder results are measurements with corresponding ratio in parentheses\n*Data with statistical significance. pa: chi-square test, pb: Student’s t test"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T64","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"T65","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"T66","span":{"begin":92,"end":100},"obj":"Disease"},{"id":"T67","span":{"begin":110,"end":118},"obj":"Disease"}],"attributes":[{"id":"A64","pred":"mondo_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A65","pred":"mondo_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A66","pred":"mondo_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A67","pred":"mondo_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Table 1 Radiological semantic features of patients in COVID-19 and non-COVID-19\nFeature Non-COVID-19 (n = 66) COVID-19 (n = 70) p value\nNumber of pure GGO\n  Total# 1.00 (0.00, 5.05) 3.50 (0.95, 8.05) 0.018b*\n  Peripheral area# 1.00 (0.00, 4.05) 2.00 (0.00, 6.05) 0.032b*\n  Central/both peripheral and central area# 0.00 (0.00, 0.00) 0.00 (0.00, 2.00) 0.001b*\nNumber of mixed GGO\n  Total# 1.00 (0.00, 3.05) 3.00 (1.00, 9.00) 0.001b*\n  Peripheral area# 0.00 (0.00, 2.00) 2.50 (1.00, 6.00) \u003c 0.001b*\n  Central/both peripheral and central area# 0.00 (0.00, 1.05) 0.00 (0.00, 2.00) 0.657b\nTotal number of consolidation\n  Consolidation# 1.00 (0.00, 3.00) 0.00 (0.00, 0.05) 0.001b*\n  Pure solid nodules# 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.309b\n  Solid nodules with GGO# 0.00 (0.00, 0.00) 0.00 (0.00, 1.00) 0.033b*\nTotal number of lesions\n  Peripheral area# 5.00 (2.00, 9.05) 7.00 (2.00, 13.00) 0.112b\n  Central area# 0.00 (0.00, 3.00) 0.00 (0.00, 1.05) 0.960b\n  Both peripheral and central area# 0.00 (0.00, 2.00) 0.00 (0.00, 2.05) 0.582b\nInterlobular septal thickening 0.009a*\n  Negative 44 (66.67%) 31 (44.29%)\n  Positive 22 (33.33%) 39 (55.71%)\nCrazy paving pattern \u003c 0.001a*\n  Negative 60 (90.91%) 32 (45.71%)\n  Positive 6 (9.09%) 38 (54.29%)\nTree-in-bud sign \u003c 0.001a*\n  Negative 37 (56.06%) 61 (87.14%)\n  Positive 29 (43.94%) 9 (12.86%)\nPleural thickening 0.030a*\n  Negative 46 (69.70%) 36 (51.43%)\n  Positive 20 (30.30%) 34 (48.57%)\nOffending vessel augmentation in lesions \u003c 0.001a*\n  Negative 55 (83.33%) 17 (24.29%)\n  Positive 11 (16.67%) 53 (75.71%)\nGGO ground-glass opacities\n#Results are median with interquartile range in parentheses, and the remainder results are measurements with corresponding ratio in parentheses\n*Data with statistical significance. pa: chi-square test, pb: Student’s t test"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T85","span":{"begin":1120,"end":1122},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T86","span":{"begin":1389,"end":1391},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T87","span":{"begin":1424,"end":1426},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T88","span":{"begin":1446,"end":1452},"obj":"http://purl.obolibrary.org/obo/UBERON_0000055"},{"id":"T89","span":{"begin":1533,"end":1535},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T90","span":{"begin":1780,"end":1784},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T91","span":{"begin":1802,"end":1806},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Table 1 Radiological semantic features of patients in COVID-19 and non-COVID-19\nFeature Non-COVID-19 (n = 66) COVID-19 (n = 70) p value\nNumber of pure GGO\n  Total# 1.00 (0.00, 5.05) 3.50 (0.95, 8.05) 0.018b*\n  Peripheral area# 1.00 (0.00, 4.05) 2.00 (0.00, 6.05) 0.032b*\n  Central/both peripheral and central area# 0.00 (0.00, 0.00) 0.00 (0.00, 2.00) 0.001b*\nNumber of mixed GGO\n  Total# 1.00 (0.00, 3.05) 3.00 (1.00, 9.00) 0.001b*\n  Peripheral area# 0.00 (0.00, 2.00) 2.50 (1.00, 6.00) \u003c 0.001b*\n  Central/both peripheral and central area# 0.00 (0.00, 1.05) 0.00 (0.00, 2.00) 0.657b\nTotal number of consolidation\n  Consolidation# 1.00 (0.00, 3.00) 0.00 (0.00, 0.05) 0.001b*\n  Pure solid nodules# 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.309b\n  Solid nodules with GGO# 0.00 (0.00, 0.00) 0.00 (0.00, 1.00) 0.033b*\nTotal number of lesions\n  Peripheral area# 5.00 (2.00, 9.05) 7.00 (2.00, 13.00) 0.112b\n  Central area# 0.00 (0.00, 3.00) 0.00 (0.00, 1.05) 0.960b\n  Both peripheral and central area# 0.00 (0.00, 2.00) 0.00 (0.00, 2.05) 0.582b\nInterlobular septal thickening 0.009a*\n  Negative 44 (66.67%) 31 (44.29%)\n  Positive 22 (33.33%) 39 (55.71%)\nCrazy paving pattern \u003c 0.001a*\n  Negative 60 (90.91%) 32 (45.71%)\n  Positive 6 (9.09%) 38 (54.29%)\nTree-in-bud sign \u003c 0.001a*\n  Negative 37 (56.06%) 61 (87.14%)\n  Positive 29 (43.94%) 9 (12.86%)\nPleural thickening 0.030a*\n  Negative 46 (69.70%) 36 (51.43%)\n  Positive 20 (30.30%) 34 (48.57%)\nOffending vessel augmentation in lesions \u003c 0.001a*\n  Negative 55 (83.33%) 17 (24.29%)\n  Positive 11 (16.67%) 53 (75.71%)\nGGO ground-glass opacities\n#Results are median with interquartile range in parentheses, and the remainder results are measurements with corresponding ratio in parentheses\n*Data with statistical significance. pa: chi-square test, pb: Student’s t test"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T16","span":{"begin":1339,"end":1357},"obj":"Phenotype"}],"attributes":[{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0031944"}],"text":"Table 1 Radiological semantic features of patients in COVID-19 and non-COVID-19\nFeature Non-COVID-19 (n = 66) COVID-19 (n = 70) p value\nNumber of pure GGO\n  Total# 1.00 (0.00, 5.05) 3.50 (0.95, 8.05) 0.018b*\n  Peripheral area# 1.00 (0.00, 4.05) 2.00 (0.00, 6.05) 0.032b*\n  Central/both peripheral and central area# 0.00 (0.00, 0.00) 0.00 (0.00, 2.00) 0.001b*\nNumber of mixed GGO\n  Total# 1.00 (0.00, 3.05) 3.00 (1.00, 9.00) 0.001b*\n  Peripheral area# 0.00 (0.00, 2.00) 2.50 (1.00, 6.00) \u003c 0.001b*\n  Central/both peripheral and central area# 0.00 (0.00, 1.05) 0.00 (0.00, 2.00) 0.657b\nTotal number of consolidation\n  Consolidation# 1.00 (0.00, 3.00) 0.00 (0.00, 0.05) 0.001b*\n  Pure solid nodules# 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.309b\n  Solid nodules with GGO# 0.00 (0.00, 0.00) 0.00 (0.00, 1.00) 0.033b*\nTotal number of lesions\n  Peripheral area# 5.00 (2.00, 9.05) 7.00 (2.00, 13.00) 0.112b\n  Central area# 0.00 (0.00, 3.00) 0.00 (0.00, 1.05) 0.960b\n  Both peripheral and central area# 0.00 (0.00, 2.00) 0.00 (0.00, 2.05) 0.582b\nInterlobular septal thickening 0.009a*\n  Negative 44 (66.67%) 31 (44.29%)\n  Positive 22 (33.33%) 39 (55.71%)\nCrazy paving pattern \u003c 0.001a*\n  Negative 60 (90.91%) 32 (45.71%)\n  Positive 6 (9.09%) 38 (54.29%)\nTree-in-bud sign \u003c 0.001a*\n  Negative 37 (56.06%) 61 (87.14%)\n  Positive 29 (43.94%) 9 (12.86%)\nPleural thickening 0.030a*\n  Negative 46 (69.70%) 36 (51.43%)\n  Positive 20 (30.30%) 34 (48.57%)\nOffending vessel augmentation in lesions \u003c 0.001a*\n  Negative 55 (83.33%) 17 (24.29%)\n  Positive 11 (16.67%) 53 (75.71%)\nGGO ground-glass opacities\n#Results are median with interquartile range in parentheses, and the remainder results are measurements with corresponding ratio in parentheses\n*Data with statistical significance. pa: chi-square test, pb: Student’s t test"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T125","span":{"begin":0,"end":79},"obj":"Sentence"},{"id":"T126","span":{"begin":80,"end":135},"obj":"Sentence"},{"id":"T127","span":{"begin":136,"end":154},"obj":"Sentence"},{"id":"T128","span":{"begin":155,"end":207},"obj":"Sentence"},{"id":"T129","span":{"begin":208,"end":270},"obj":"Sentence"},{"id":"T130","span":{"begin":271,"end":358},"obj":"Sentence"},{"id":"T131","span":{"begin":359,"end":378},"obj":"Sentence"},{"id":"T132","span":{"begin":379,"end":431},"obj":"Sentence"},{"id":"T133","span":{"begin":432,"end":496},"obj":"Sentence"},{"id":"T134","span":{"begin":497,"end":583},"obj":"Sentence"},{"id":"T135","span":{"begin":584,"end":613},"obj":"Sentence"},{"id":"T136","span":{"begin":614,"end":674},"obj":"Sentence"},{"id":"T137","span":{"begin":675,"end":739},"obj":"Sentence"},{"id":"T138","span":{"begin":740,"end":809},"obj":"Sentence"},{"id":"T139","span":{"begin":810,"end":833},"obj":"Sentence"},{"id":"T140","span":{"begin":834,"end":896},"obj":"Sentence"},{"id":"T141","span":{"begin":897,"end":955},"obj":"Sentence"},{"id":"T142","span":{"begin":956,"end":1034},"obj":"Sentence"},{"id":"T143","span":{"begin":1035,"end":1073},"obj":"Sentence"},{"id":"T144","span":{"begin":1074,"end":1108},"obj":"Sentence"},{"id":"T145","span":{"begin":1109,"end":1143},"obj":"Sentence"},{"id":"T146","span":{"begin":1144,"end":1174},"obj":"Sentence"},{"id":"T147","span":{"begin":1175,"end":1209},"obj":"Sentence"},{"id":"T148","span":{"begin":1210,"end":1242},"obj":"Sentence"},{"id":"T149","span":{"begin":1243,"end":1269},"obj":"Sentence"},{"id":"T150","span":{"begin":1270,"end":1304},"obj":"Sentence"},{"id":"T151","span":{"begin":1305,"end":1338},"obj":"Sentence"},{"id":"T152","span":{"begin":1339,"end":1365},"obj":"Sentence"},{"id":"T153","span":{"begin":1366,"end":1400},"obj":"Sentence"},{"id":"T154","span":{"begin":1401,"end":1435},"obj":"Sentence"},{"id":"T155","span":{"begin":1436,"end":1486},"obj":"Sentence"},{"id":"T156","span":{"begin":1487,"end":1521},"obj":"Sentence"},{"id":"T157","span":{"begin":1522,"end":1556},"obj":"Sentence"},{"id":"T158","span":{"begin":1557,"end":1583},"obj":"Sentence"},{"id":"T159","span":{"begin":1584,"end":1727},"obj":"Sentence"},{"id":"T160","span":{"begin":1728,"end":1789},"obj":"Sentence"},{"id":"T161","span":{"begin":1790,"end":1806},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 1 Radiological semantic features of patients in COVID-19 and non-COVID-19\nFeature Non-COVID-19 (n = 66) COVID-19 (n = 70) p value\nNumber of pure GGO\n  Total# 1.00 (0.00, 5.05) 3.50 (0.95, 8.05) 0.018b*\n  Peripheral area# 1.00 (0.00, 4.05) 2.00 (0.00, 6.05) 0.032b*\n  Central/both peripheral and central area# 0.00 (0.00, 0.00) 0.00 (0.00, 2.00) 0.001b*\nNumber of mixed GGO\n  Total# 1.00 (0.00, 3.05) 3.00 (1.00, 9.00) 0.001b*\n  Peripheral area# 0.00 (0.00, 2.00) 2.50 (1.00, 6.00) \u003c 0.001b*\n  Central/both peripheral and central area# 0.00 (0.00, 1.05) 0.00 (0.00, 2.00) 0.657b\nTotal number of consolidation\n  Consolidation# 1.00 (0.00, 3.00) 0.00 (0.00, 0.05) 0.001b*\n  Pure solid nodules# 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.309b\n  Solid nodules with GGO# 0.00 (0.00, 0.00) 0.00 (0.00, 1.00) 0.033b*\nTotal number of lesions\n  Peripheral area# 5.00 (2.00, 9.05) 7.00 (2.00, 13.00) 0.112b\n  Central area# 0.00 (0.00, 3.00) 0.00 (0.00, 1.05) 0.960b\n  Both peripheral and central area# 0.00 (0.00, 2.00) 0.00 (0.00, 2.05) 0.582b\nInterlobular septal thickening 0.009a*\n  Negative 44 (66.67%) 31 (44.29%)\n  Positive 22 (33.33%) 39 (55.71%)\nCrazy paving pattern \u003c 0.001a*\n  Negative 60 (90.91%) 32 (45.71%)\n  Positive 6 (9.09%) 38 (54.29%)\nTree-in-bud sign \u003c 0.001a*\n  Negative 37 (56.06%) 61 (87.14%)\n  Positive 29 (43.94%) 9 (12.86%)\nPleural thickening 0.030a*\n  Negative 46 (69.70%) 36 (51.43%)\n  Positive 20 (30.30%) 34 (48.57%)\nOffending vessel augmentation in lesions \u003c 0.001a*\n  Negative 55 (83.33%) 17 (24.29%)\n  Positive 11 (16.67%) 53 (75.71%)\nGGO ground-glass opacities\n#Results are median with interquartile range in parentheses, and the remainder results are measurements with corresponding ratio in parentheses\n*Data with statistical significance. pa: chi-square test, pb: Student’s t test"}